Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients (Q42199832)

18 October 2017

title

Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients (English)

1 reference

18 October 2017

1 reference

16

1 reference

18 October 2017

Jan-Christian Wasmuth

Carolynne Schwarze-Zander

11

object named as

Jan-Christian Wasmuth

0 references

5

object named as

Carolynne Schwarze-Zander

1 reference

18 October 2017

13

Ulrich Spengler

1 reference

18 October 2017

Evrim Anadol

1

1 reference

18 October 2017

Robert Schierwagen

2

1 reference

18 October 2017

Natalia Elfimova

3

1 reference

18 October 2017

Katharina Tack

4

1 reference

18 October 2017

Hanna Eischeid

6

1 reference

18 October 2017

Andrea Noetel

7

1 reference

18 October 2017

Christoph Boesecke

8

1 reference

18 October 2017

Christian Jansen

9

1 reference

18 October 2017

Leona Dold

10

1 reference

18 October 2017

Jan-Christian Wasmuth

11

1 reference

18 October 2017

Christian P Strassburg

12

1 reference

18 October 2017

Jürgen Kurt Rockstroh

14

1 reference

18 October 2017

Margarete Odenthal

15

1 reference

18 October 2017

language of work or name

English

0 references

publication date

20 November 2014

1 reference

18 October 2017

1 reference

18 October 2017

volume

61

1 reference

18 October 2017

issue

1

1 reference

18 October 2017

page(s)

46-55

1 reference

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Increasing burden of liver disease in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Most mammalian mRNAs are conserved targets of microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Circulating microRNAs: promising candidates serving as novel biomarkers of acute hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Treatment of HCV infection by targeting microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

The role of microRNAs in HIV-1 pathogenesis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

HIV-1 infected peripheral blood mononuclear cells modulate the fibrogenic activity of hepatic stellate cells through secreted TGF-β and JNK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Mir-34a is upregulated during liver regeneration in rats and is associated with the suppression of hepatocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

MicroRNAs in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Hepatitis B virus-specific miRNAs and Argonaute2 play a role in the viral life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Suppression of microRNA-silencing pathway by HIV-1 during virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Liver-specific microRNA-122: Biogenesis and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Kinetics of miR-122 expression in the liver during acute HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Epigenetic regulation of miR-34a expression in alcoholic liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Hepatic microRNA profiles offer predictive and mechanistic insights after exposure to genotoxic and epigenetic hepatocarcinogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Expression variability of absorption, distribution, metabolism, excretion-related microRNAs in human liver: influence of nongenetic factors and association with gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Comprehensive miRNome and in silico analyses identify the Wnt signaling pathway to be altered in the diabetic liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

inferred from DOI database lookup

7 January 2021

based on heuristic

Liver-specific microRNAs as biomarkers of nanomaterial-induced liver damage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.27369

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.27369

1 reference

18 October 2017

1 reference